NCT00199446View on ClinicalTrials.gov

Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

October 31, 2006

Conditions

Sleep DisorderRestless Legs Syndrome

Interventions

DRUG

Istradefylline (KW-6002)

Trial Locations (1)

08540

Kyowa Pharmaceutical Inc., Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.

All Listed Sponsors

collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Kyowa Kirin, Inc.

INDUSTRY